Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05074160 · ClinicalTrials.gov registry record
OCS Liver Perfusion (OLP) Post-Approval Registry
A clinical trial of Liver Transplant, sponsored by TransMedics.
- Active
- Registry status
- 166
- Enrollment target
- 9
- Study locations
NCT05074160 is a study of Liver Transplant that is active but no longer recruiting, run by TransMedics. The registered enrollment target is 166 participants, below the 5,450-participant average among 19 other Liver Transplant trials with a reported enrollment target (97% lower). The trial reports 9 study locations across 8 states.
The verdict
NCT05074160, a study of Liver Transplant, is active but no longer recruiting, sponsored by TransMedics.
- ACTIVE NOT RECRUITING
- Registry status
- 166 participants
- Enrollment target
- 9
- Study locations
Study Summary
The objective of the OLP Registry is to collect more data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on OCS Liver System according to the approved indication and the OCS device performance in the real-world setting.
Conditions Studied
Interventions
- DEVICE OCS Liver
Study Locations (9)
California
- University of California San Diego - La Jolla
- University of California San Francisco - San Francisco
Alabama
- University of Alabama - Birmingham
Georgia
- Emory - Atlanta
Massachusetts
- Massachusetts General Hospital - Boston
Michigan
- Henry Ford Hospital - Detroit
Nebraska
- University of Nebraska Medical Center - Omaha
North Carolina
- Duke Medical Center - Durham
Texas
- Houston Methodist - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2021-10-14 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05074160
The ClinicalTrials.gov registry entry for NCT05074160 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,450-participant average among 19 other Liver Transplant trials with a reported enrollment target (97% lower). The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which OCS Liver is the first listed.
NCT05074160 reports 9 study locations spanning 8 distinct geographic areas - top geographies include California, Alabama, Georgia.
Frequently Asked Questions
What is clinical trial NCT05074160 about?
NCT05074160 is a clinical study titled "OCS Liver Perfusion (OLP) Post-Approval Registry". The objective of the OLP Registry is to collect more data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on OCS Liver System according to the approved indication and the OCS device performance in the real-world setting.
What is the current status of trial NCT05074160?
This trial is currently active not recruiting. The enrollment target is 166 participants. The study started on 2021-10-14. Estimated completion is 2026-06.
What conditions does trial NCT05074160 study?
This clinical trial studies the following conditions: Liver Transplant.
What interventions are being tested in trial NCT05074160?
The interventions under investigation include: OCS Liver (DEVICE).
Who is sponsoring clinical trial NCT05074160?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05074160 being conducted?
This trial has 9 study locations across Alabama, California, Georgia, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
RECRUITING · Phase 2
-
US National OCS Liver Perfusion (OLP) Registry
RECRUITING
-
Liver Transplant CGM
RECRUITING
-
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
RECRUITING · NA
-
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
RECRUITING · Phase 2
-
EVR and EPO for Liver Transplant Tolerance
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.